PharmaShots Weekly Snapshots (January 08 – January 12, 2024)
This week PharmaShots’ news was all about the updates on M&A, Pharma, Clinical Trials, Regulatory & MedTech. Check out our full report below:
The US FDA Approved Ligand Pharmaceuticals’ Zelsuvmi for the Treatment of Molluscum Contagiosum
Read More: Ligand Pharmaceuticals
The European Commission Approved UCB’s Rystiggo (rozanolixizumab) to Treat Adults with Generalized Myasthenia Gravis (gMG)
Read More: UCB
The US FDA has Accepted the IND Application of Caliway’s CBL-514 for Dercum’s Disease
Read More: Caliway Biopharmaceuticals
The NMPA Approves Eisai and Biogen’s Leqembi (Lecanemab) for the Treatment of Alzheimer’s Disease
Read More: Eisai & Biogen
The US FDA Accepts Pfizer’s sBLA for Tivdak for Priority Review to Treat Cervical Cancer
Read More: Pfizer
The NMPA approves GSK’s Nucala (mepolizumab) for the Treatment of Severe Eosinophilic Asthma
Read More: GSK
The US FDA Accepts HUTCHMED’s NDA for Sovleplenib and Grants Priority Review for the Treatment of Primary Immune Thrombocytopenia (PIT)
Read More: HUTCHMED
China’s NMPA Grants IND Approval to Fermion’s FZ008-145 for Pain Relief
Read More: Fermion
The EC Grants Conditional Marketing Authoriztaion to Mirati Therapeutics’ Krazati (adagrasib) for Advanced Non-Small Cell Lung Cancer (NSCLC)
Read More: Mirati Therapeutics
RemeGen's RC88 Receives FTD from the US FDA for the Treatment of Ovarian Cancer
Read More: RemeGen
SanReno Therapeutics Reports Acquisition by Novartis for the Advancement of Transformative Medicines for Kidney Disease
Read More: Novartis & SanReno Therapeutics
For an Aggregate of ~$2.0B, Johnson & Johnson to Acquire Ambrx Biopharma
Read More: Johnson & Johnson & Ambrx Biopharma
For an Aggregate of $680M, Merck & Co. to Acquire Harpoon Therapeutics
Read More: Merck & Co. & Harpoon Therapeutics
For an Aggregate of ~$1.4B, GSK to Acquire Aiolos Bio
Read More: GSK & Aiolos Bio
Galvanize Therapeutics Reports Acquisition of its Electrophysiology Technology Division by CardioFocus
Read More: CardioFocus & Galvanize Therapeutics
Merck Initiates a Series of P-III Trials for Bomedemstat, Nemtabrutinib, MK-2870 and MK-5684 to Treat Solid Tumors
Read More: Merck
Novartis Highlights the P-III Results for Scemblix (asciminib) to Treat Newly Diagnosed Chronic Myeloid Leukemia
Read More: Novartis
Innovent Highlight the P-III Results for Mazdutide (IBI362) to Treat Adults with Overweight or Obesity
Read More: Innovent
Alcon Highlights the P-III Results for AR-15512 to Treat Dry Eye Disease
Read More: Alcon
SELLAS Highlights Updated Data from its P-IIa Study of SLS009 for R/R Acute Myeloid Leukemia (AML)
Read More: SELLAS Life Sciences
bridgebio Highlights the P-III Results for Acoramidis to Treat Transthyretin Amyloid Cardiomyopathy
Read More: bridgebio
Renovion Reports Completion of Patient Recruitment in the P-II (CLIMB) Study of ARINA-1 for Bronchiectasis
Read More: Renovion
Medison Pharma Sings an Agreement with Regeneron Pharmaceuticals to Commercialize Libtayo (cemiplimab) Globally for Cancer Treatment
Read More: Medison Pharma & Regeneron Pharmaceuticals
ConcertAI and Caris Life Sciences Sign a Collaboration Agreement with AbbVie to Enhance Research and Development Efforts Towards Cancer Treatment
Read More: ConcertAI, Caris Life Sciences & AbbVie
Henlius Partners with Sermonix to Develop Lasofoxifene for Breast Cancer
Read More: Henlius & Sermonix
SyntheticGestalt Partners with Enamine to Create AI-Based Model for Drug Discovery
Read More: Xcell Biosciences & ElevateBio
Xcell Biosciences Collaborates with ElevateBio to Develop Technology for Cell and Gene Therapies
Read More: SyntheticGestalt & Enamine
Transforming Women's Health with Technology: The US FDA Approves Qvin’s Q-Pad Kit to Track Diabetes Using Menstrual Sample Testing
Read More: Qvin
Ultromics Signs a a Collaboration Agreement with Pfizer to Enhance the Development of EchoGo for the Detection of Cardiac Amyloidosis
Read More: Ultromics & Pfizer
The US FDA Grants IDE Approval to Endovascular Engineering’s Hēlo Thrombectomy System for Pulmonary Embolism
Read More: Endovascular Engineering
Related Post:- PharmaShots Weekly Snapshots (January 01 – January 05, 2023)
Tags
Shivani was a content writer at PharmaShots. She has a keen interest in recent innovations in the life sciences industry. She was covering news related to Product approvals, clinical trial results, and updates. We can be contacted at connect@pharmashots.com.
